Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Gerald Lipshutz, M.D., D.D.S.
Gerald Lipshutz, M.D., D.D.S.


Kidney Transplantation
Liver Transplantation
Pancreas Transplantation
Surgery General

General Information:



Associate Professor in Residence, Department of Surgery and Department of Urology
Physician, Department of Surgery, Liver and Pancreas Transplantation
Member, JCCC Tumor Immunology Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center


Medical Degree:
M.D., UCLA School of Medicine, 1993
D.D.S., UCLA School of Dentistry, 1985 - 1989
M.S., UCLA Graduate Division, 1986 - 1990


Medical Board Certification(s):
Surgery, American Board of Surgery, 2003

Contact Information:

(310) 794-7788 Patient appointments
Liver and Pancreas Transplantation:
(310) 825-5318 Adult Liver Transplant Referral
(310) 825-5318 Hepatobiliary Surgery Referral
(310) 825-5318 Intestinal Transplant Referral
(310) 825-5318 Liver Cancer Center Referral
(310) 825-5318 Living Donor Liver Transplant Referral
(310) 825-6301 Medical center Page Operator
(310) 825-6836 Pancreas Transplant Referral
(310) 825-5318 Patient appointments
(310) 206-6134 Pediatric Liver Transplant Referral
(310) 206-3748 Referring physician
(310) 206-7760 Fax
(310) 825-8206

Practice Information:

Clinical Interest(s):
Transplantation in the Elderly
Kidney Transplantation
Liver Transplantation
Pancreas Transplantation

Scientific Interest(s):

Achieving persistent transgene expression at therapeutic levels is a prerequisite for effective gene therapy for inherited disorders of intracellular or secreted proteins. In adult animals, delivery and expression of genes has resulted in immune responses to the gene product and to vector-associated proteins that limit or abrogate expression. Dr. Gerald Lipshutz's investigations aim to study the immune response to proteins expressed prenatally and on into adulthood, after in utero delivery of viral vectors expressing foreign transgenes. Re-administration of viral vectors during adulthood, after prenatal vector delivery, would allow for augmentation of expression postnatally with the goal of achieving therapeutic levels of gene expression. Understanding the mechanism of this immune unresponsiveness may also be important in the treatment of certain malignancies such as melanoma.

Selected Cancer-Related Publications:

Lipshutz GS, Hiatt J, Ghobrial RM, Farmer DG, Martinez MM, Yersiz H, Gornbein J, Busuttil RW. Outcome of liver transplantation in septuagenarians: a single-center experience. Arch Surg. 2007 Aug;142(8):775-81; discussion 781-4.

Lipshutz GS, Baxter-Lowe LA, Nguyen T, Jones KD, Ascher NL, Feng S. Death from donor-transmitted malignancy despite emergency liver retransplantation. Liver Transpl. 2003 Oct;9(10):1102-7.

Lipshutz GS, Titre D, Brindle M, Bisconte AR, Contag CH, Gaensler KM. Comparison of gene expression after intraperitoneal delivery of AAV2 or AAV5 in utero. Mol Ther. 2003 Jul;8(1):90-8.

Lipshutz GS, Brennan TV, Warren RS. Thorotrast-induced liver neoplasia: a collective review. J Am Coll Surg. 2002 Nov;195(5):713-8. Review.